Amend HB 2163 by adding the following appropriately numbered 
SECTION to the bill and renumbering subsequent SECTIONS of the bill 
accordingly:
	SECTION ___.  (a)  In this section, "pharmacy care 
management services" means services provided by a pharmacy to 
support patients receiving treatment or therapy through a specialty 
pharmacy drug or therapy and maximize adherence to the drug or 
therapy, including:
		(1)  significant caregiver and provider contact and 
education regarding the relevant disease, disease prevention and 
treatment, and counseling related to drug indications, benefits, 
risks, complications, and appropriate use of the prescribed drug or 
therapy;
		(2)  patient compliance services, including 
coordination of provider visits with delivery of the specialty drug 
or therapy to the provider, compliance with the dosing regimen, 
patient reminders, compilation of data, and assisting providers in 
the development of compliance programs; and
		(3)  tracking services, including developing ordering 
processes with a provider, screening referrals, and tracking a 
patient's weight for dosing requirements.
	(b)  The Health and Human Services Commission shall study the 
feasibility of establishing separate reimbursement rates under the 
Medicaid vendor drug program for pharmacies that provide pharmacy 
care management services to patients who are administered specialty 
pharmacy drugs, including drugs indicated for the prophylaxis of 
respiratory syncytial virus, blood factor, or any other biologic or 
therapy that requires complex care.
	(c)  In conducting the study under Subsection (b) of this 
section, the Health and Human Services Commission shall consult 
with the Centers for Medicare and Medicaid Services and may 
consider the adoption of pharmacy care management services 
reimbursement for pharmacy services adopted by other state Medicaid 
programs.
	(d)  The Health and Human Services Commission shall seek 
information from specialty pharmacy providers or other sources 
regarding the costs of providing pharmacy care management services.
	(e)  Not later than September 1, 2010, the Health and Human 
Services Commission shall submit a written report of the results of 
the study conducted under Subsection (b) of this section to the 
legislature.